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Objectives: We aimed to perform a systematic review of the literature to identify interventions that may
facilitate ambulatory laparoscopic cholecystectomy (LC).
Methods: The PubMed and CENTRAL databases were interrogated for key MeSH headings. To be
eligible for systematic review, trials were required to include outcome measures of postoperative pain,
nausea or vomiting and time to discharge following LC. Interventions were subsequently assessed for the
level of evidence and grade of recommendation given.
Results: A total of 331 trials were identified, 68 of which met the predefined study inclusion criteria.
Interventions which met Level I, Grade A recommendation included the administration of 8 mg i.v.
dexamethasone, preoperative administration of analgesia including the use of non-steroidal anti-
inflammatory or COX II inhibitors, intraoperative use of an anti-emetic, pre-incisional use of bupivacaine,
administration of intraperitoneal bupivacaine on establishment of pneumoperitoneum, and avoidance of
drains.
Conclusions: High-quality evidence describing interventions that minimize barriers to ambulatory LC
exists. Further studies will be required to determine the optimal combination of these interventions.
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Introduction
Laparoscopic cholecystectomy (LC) is currently accepted as the
reference standard for the management of symptomatic or com-
plicated gallstone disease. There is now increasing evidence to
support ambulatory LC as the standard of care as a result of its
ability to improve patient recovery and significantly reduce hos-
pital stay.1–4 Laparoscopic cholecystectomy would appear to be an
ideal operation for ambulatory surgery because it is of short dura-
tion, uses small incisions, carries a low rate of immediate compli-
cations and does not disrupt gastrointestinal homeostasis. Despite
this, several series describing ambulatory LC have reported inpa-
tient admission rates of up to 20%,mainly for nausea, vomiting or
uncontrolled pain.5–7
The aim of this study was to develop an evidence-based
approach to ambulatory LC by systematically reviewing all pub-
lished randomized controlled trials (RCTs) of pre-, intra- and
postoperative interventions aimed at improving postoperative
pain, postoperative nausea and vomiting (PONV), patient satis-
faction and general well-being following LC.
Materials and methods
Search strategy
The search sought to identify published RCTs analysing the effi-
cacy of preoperative (initiated prior to anaesthetic room), intra-
operative (initiated in the anaesthetic or operating room) and
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postoperative (initiated in recovery or beyond) interventions
during LC that can optimize early discharge and enhance patient
recovery.
A search of the PubMed and CENTRAL (Cochrane Central
Register of Controlled Trials) databases for materials published
from 1990 to December 2009 was performed using the follo-
wing key MeSH terms: cholecystectomy; laparoscopic/; laparo-
scopic cholecystectomy.mp; ambulatory surgical procedures/;
anaesthesia/; preoperative care/; postoperative care/; intraopera-
tive care/; patient education as topic/ OR patient education.mp,
and drainage/ OR drainage.mp. The search was limited to studies
published in the English language, studies in humans and RCTs.
Eligibility criteria
This search was based on two hypotheses: firstly, that ambulatory
LC would prove to be feasible, safe and effective, and, secondly,
that pain, PONV and other postoperative complications resulting
in low levels of patient satisfaction would emerge as barriers to
ambulatory LC. Publications debating the above hypotheses were
excluded. Other exclusion criteria were: (i) a focus on compari-
sons of patient characteristics as predictors of success in ambula-
tory LC; (ii) indistinguishable or mixed-participant populations
of LC patients with other surgical patients; (iii) primary outcome
measures other than postoperative pain, PONV, patient satisfac-
tion, time to discharge or other determinants of discharge of
patients postoperatively; (iv) publication in languages other than
English; (v) non-human participants; (vi) non-RCT formats, and
(vii) studies with a Jadad score8 of <3.
Study selection
Initial selection
Potential articles were identified by the search strategy described
above. Their titles and abstracts were manually screened by the
primary reviewer and the eligibility criteria were applied. Any
contentious issues were then resolved by the consensus of all
authors. Duplicate studies and studies that did not meet eligibility
criteria were then excluded.
Data extraction
Eligible manuscripts were analysed according to data extraction
completed as described in the Appendix and allocated a Jadad
score.8 Publications with a Jadad score of <3 were subsequently
excluded from review.9–11 Consensus on Jadad scores was achieved
by at least two authors.
A summary statement for each intervention was constructed on
the calculated strength of evidence12,13 (Table 1) and grade of
recommendation12–15 (Table 2).
Results
The search yielded 331 potential articles; 263 articles were
excluded from the analysis as they did not meet the inclusion
criteria (Fig. 1). Of the 68 manuscripts included for analysis, 28
(41%) had a Jadad score of 3, 23 (34%) had a score of 4, and 17
(25%) had a score of 5.
Preoperative interventions
Correction of preoperative dehydration is likely to be
beneficial (Level IB)
Two well-conducted studies6,16 assessed the effect of preoperative
carbohydrate (CHO) drinks with divergent conclusions. Impor-
tantly, the two trials differed in their anaesthesia protocols. In the
trial in which significant improvements in postoperative param-
eters were measured,6 patients received an increased volume of
intraoperative i.v. fluid compared with patients in the trial in
which no significant difference was observed. Hence the routine
use of preoperative CHO drinks cannot currently be recom-
mended and further studies are indicated. In an effort to assess the
effect of preoperative dehydration, Adanir et al.5 performed a
double-blind RCT (n = 210) comparing pre- and intraoperative
i.v. fluid replacement for an assumed fluid deficit caused by an
overnight fast. This well-powered study showed that PONV was
significantly reduced in those receiving preoperative rehydration
(48%) compared with those receiving intraoperative replacement
alone (64%).
Dexamethasone 8 mg i.v. should be given preoperatively
(Level IA)
Seven randomized trials17–23 assessed the effect of dexamethasone
on PONV. All seven trials used 8 mg of i.v. dexamethasone as the
Table 1 Requirements to meet each level of evidence12,13
Level Evidence required
I Evidence from RCTs with significant P-values, adequate
sample size, and appropriate methodology that is well
described
II Evidence from RCTs with insignificant P-values, inadequate
sample size, or inappropriate methodology that is not
well described
III Evidence from non-randomized trials using a
contemporaneous cohort of controls
IV Evidence from non-randomized trials using a historical
cohort of controls
V Evidence from case series that do not describe controls
RCT, randomized controlled trial.
Table 2 Grade of recommendation based on available level of
evidence12–15
Grade Strength of evidence
A Supported by two or more Level I studies without
conflicting evidence from other Level I studies
B Supported by two or more Level I studies with conflicting
evidence from other Level I studies OR supported by
only one Level I or two or more Level II studies
C Supported by studies of Level III–V evidence
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standard dose, although the timing of dexamethasone adminis-
tration varied from as early as 90 min preoperatively to as late as
induction of anaesthesia. The incidence of PONV ranged from
58% to 75% in the placebo groups and from 20% to 35% in the
dexamethasone groups. In two trials,20,21 dexamethasone was
given in addition to a serotonin receptor antagonist, resulting in a
3–5% incidence of PONV, compared with a 17–18% incidence in
the group receiving a serotonin antagonist alone. Interestingly,
two of the placebo-controlled trials20,23 showed a significant
reduction in postoperative pain scores with the administration of
an anti-emetic. In both trials, dexamethasone was administered
90 min prior to surgery, whereas in the two placebo-controlled
trials,17,22 in which no reduction in postoperative pain scores was
observed with dexamethasone, it was administered at anaesthetic
induction. Favourable outcomes appear to be limited to dexam-
ethasone as an equipotent dose of oral prednisone (50 mg)
showed no significant difference in outcomes measured.24
Patient education improves knowledge and recall but
does not affect postoperative pain or PONV (Level IIB)
Two randomized trials25,26 analysed the effect of preoperative
patient education. Although both trials showed that education
increased patient knowledge recall, neither showed an improve-
ment in postoperative pain scores or PONV.
Preoperative administration of NSAIDs or COX II
inhibitors is indicated (Level IA). A multimodal approach
may have an additive effect (Level IB)
In total, nine studies addressed the role of single-agent preopera-
tive analgesia in improving postoperative outcomes. Three
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Full texts retrieved and screened in 
depth for further application of 
eligibility criteria and data extraction 
After second screening = 68 
68 RCTs included in 
systematic review for analysis 
Excluded: duplicate, non-RCT,
non-English-
language studies = 257
Excluded for Jadad 
scale score: < 3 = 3
Study participant population was not 
specific for laparoscopic 
cholecystectomy patients = 3
331 articles screened by title and 
abstract and applied eligibility 
criteria
After screening = 74 
Literature search of databases: PubMed and CENTRAL 
Limits: English-language, Humans, RCTs  
[See Protocol] all 8 searches = 331 
Figure 1 Results of search strategy and application of exclusion criteria for randomized trials assessing interventions that will facilitate
ambulatory laparoscopic cholecystectomy. RCT, randomized controlled trial
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studies27–29 compared non-steroidal anti-inflammatory drugs
(NSAIDs) with placebo. All three studies showed decreased post-
operative pain scores and a reduced requirement for postoperative
opioid analgesia. Four trials2,30–32 evaluated COX II inhibitors. All
four trials showed a reduction in postoperative pain and two
trials30,31 reported increased patient satisfaction.
Yu et al.33 administered clonidine 150 mcg orally 60–90 min
prior to anaesthetic induction and showed that patients in the
clonidine group required less analgesia in the first 24 h postop-
eratively compared with those in the placebo group. Similarly, the
analgesic efficacy of a g-aminobutyric acid analogue, pregabalin,
significantly reduced postoperative pain in a single trial.34
Five trials35–39 described outcomes in patients receiving multi-
modal analgesia. They used a variety of analgesic combinations
which included NSAIDs, COX II inhibitors, oxycodone, gabapen-
tin, local anaesthetic and intrathecal morphine and thus are not
directly comparable. However, four of these trials36–39 showed a
significant reduction in postoperative pain without a reduction in
PONV. In a trial reported by Gilron et al.,39 no reduction in post-
operative pain scores was seen in patients receiving a multimodal
approach compared with those receiving a single agent alone.
Intraoperative interventions
A liberal intraoperative fluid regimen is superior to a
restrictive approach (Level IB)
Holte et al.40 conducted a double-blind RCT of 48 patients under-
going elective LC. The aim of the study was to compare two
different intraoperative i.v. fluid regimens of, respectively, a liberal
(40 ml/kg) and a restrictive (15 ml/kg) administration of lactated
Ringer’s solution. The results overwhelmingly favoured the liberal
intraoperative fluid regimen, in which all physiological subjective
recovery measures and clinical outcomes were significantly
improved. Although the study was underpowered, hospital stay in
the liberal i.v. fluid group was significantly shorter than that in the
restricted-fluid group [i.e. of the patients eligible for same-day
discharge, 21 of 22 patients in the liberal i.v. fluid group were
discharged compared with only 15 of 23 in the restricted-fluid
group (P = 0.02)]. It should be noted that this trial applied sig-
nificant exclusion criteria which excluded half the patients in the
liberal i.v. fluid arm from analysis for reasons of significant car-
diovascular comorbidity.
Intraoperative magnesium or esmolol infusion may be
useful in reducing postoperative pain (Level IB)
One trial examined the effect of an intraoperative magnesium
infusion on postoperative pain following LC. Mentes et al.41 ran-
domized 83 patients to receive either a 50-mg/kg infusion of mag-
nesium sulphate (MgSO4) or placebo. The treatment group
showed significant reductions in postoperative pain scores and
significantly reduced patient-controlled analgesia use. A further
trial assessed the effect of an esmolol infusion and found that it
reduced PONV, decreased postoperative pain and led to earlier
discharge.42
Pneumoperitoneal pressure of 9 mmHg may be useful
in reducing postoperative pain scores (Level IB)
Five trials43–47 assessed the effect of pneumoperitoneum on post-
operative pain. Low-pressure pneumoperitoneum was defined as
pressure of 7–9 mmHg and standard pressure as pressure of
12–13 mmHg. Although three trials44–46 showed reduced pain
scores with low-pressure pneumoperitoneum, two trials did not.
These included a well-powered study43 and a further trial per-
formed in patients undergoing ambulatory cholecystectomy.45
Pre-incisional local anaesthesia to wounds and
peritoneum should be used (Level IA)
Thirteen trials48–60 examined the use of local anaesthesia (LA)
during LC. Intraperitoneal LA was shown to be beneficial in seven
of nine trials.48–54,57 In two trials,49,50 in which no difference
emerged, LA was administered at the end of the procedure.
Karaaslan et al.54 showed the effect of LA to be greatest when it was
administered at the commencement of pneumoperitoneum.
Alkhamesi et al.51 showed aerosolized LA to be more effective than
injected intraperitoneal LA. Eight trials51,53,55–60 examined the
effect of incisional LA, including two53,57 which combined this
with intraperitoneal LA. Of these trials, only two did not show a
significant benefit with incisional LA and one51 of these adminis-
tered it postoperatively. Pre-incisional LA has been shown to be
superior to post-incisional infiltration.58 Although Ure et al.59
concluded no effect from pre-incisional LA, they reported a sig-
nificant increase in the number of pain-free patients in the post-
operative period. Two trials53,57 showed that the combination of
intraperitoneal and incisional LA is superior to either method
alone and reduces PONV.57
Intra-abdominal drains should not be used routinely
(Level IA)
Three trials examined the effect of placing an intra-abdominal
drain. Two of these trials1,61 placed sub-hepatic drains. Both were
well powered and showed a significant increase in postoperative
pain using a visual analogue scale (VAS) in patients in whom
sub-hepatic drains were placed compared with controls. In the
third trial, Nursal et al.62 placed sub-diaphragmatic drains with
the aim of removing residual gas following pneumoperitoneum.
No differences in use of postoperative analgesia or anti-emetics
were observed.
Other intraoperative interventions
Other intraoperative interventions aimed at reducing postopera-
tive pain included two trials63,64 assessing the effect of ketamine.
Neither trial showed any clinically significant improvement in
postoperative pain. Boccara et al.65 found that ketoprofen given
just prior to induction was superior to both ketoprofen given at
the end of the procedure or propacetamol, further supporting the
use of preoperative NSAIDs. Cekmen et al.66 studied the efficacy
of transcutaneous electrical nerve stimulation (TENS) on PONV
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and found it to be effective in reducing PONV and decreasing the
need for analgesia and anti-emetics (Level IIB).
Anti-emetics significantly reduce PONV (Level IA).
Serotonin antagonists droperidol, metoclopramide,
gabapentin and dixyrazine are all effective in reducing
PONV (Level IB). Total i.v. anaesthesia combined with
anti-emetics significantly reduces PONV compared with
either alone (Level IB)
Two trials compared volatile anaesthesia with total i.v. anaesthesia
(TIVA).67,68 Both showed that patients receiving TIVA took longer
to achieve eye opening in recovery; however, this did not translate
to a significant delay in discharge from either recovery or hospital.
Additionally, Raeder et al.67 showed a significant reduction in
PONV and pain in those who received TIVA, a finding further
supported by Habib et al.69 In this study, patients receiving a mul-
timodal approach to PONV with anti-emetics and propofol were
shown to have a significantly lower incidence of PONV and
increased satisfaction with the management of their PONV com-
pared with those receiving propofol alone or inhalational anaes-
thesia with anti-emetics.
Eight studies7,70–76 evaluated the efficacy of different anti-emetic
regimens in patients undergoing LC. Two placebo-controlled tri-
als7,73 showed serotonergic antagonists such as ondansetron to be
effective in reducing postoperative nausea7 and vomiting.7,73 Addi-
tionally, three studies70–72 compared ondansetron with droperidol,
metoclopramide or both and found no differences. In a random-
ized, placebo-controlled trial of 250 patients undergoing LC,
Pandey et al.74 assessed the efficacy of 600 mg gabapentin on
PONV in the first postoperative 24 h. They found a statistically
significant reduction in the incidence of PONV in the gabapentin
group, but the severity of PONV was similar in both groups.
Additionally, in patients given gabapentin, fentanyl requirements
were reduced, which is consistent with the previously reported
opioid-sparing effects of this treatment.75 The efficacy of dixyra-
zine, a phenothiazine derivative, was studied by Glaser et al.76 in a
trial of 197 patients. The authors reported significantly more
patients without PONV and fewer patients requiring rescue anal-
gesia in the dixyrazine group.
Other anaesthetic techniques trialled have included epidural77
and regional78 anaesthesia. Only intercostal nerve blocks have
been shown to reduce postoperative pain scores, although their
clinical significance was debatable78 (Level IB).
Postoperative interventions
One RCT79 examined the effect of postoperative melatonin.
Although the treatment group showed a reduction in sleep
latency, no improvement in sleep quality, fatigue or generalized
well-being emerged and therefore the authors concluded that this
treatment could not be recommended (Level IIB).
In an RCT of 73 patients, Puolakka et al.80 assessed the efficacy
of parecoxib 40 mg vs. 80 mg placebo. All study drugs were
administered at the end of anaesthesia. No significant differences
between the groups emerged with respect to postoperative fenta-
nyl consumption, incidence of PONV or use of anti-emetics.
Despite the results of this well-powered study, it analysed out-
comes at 20 h postoperatively and the authors acknowledged that
this may not have been a long enough timeframe to study the
analgesic efficacy of coxibs (Level IIB).
Discussion
Laparoscopic cholecystectomy remains one of the most com-
monly performed general surgical operations in both the acute
and elective settings. Despite over two decades of experience, and
the procedure’s suitability to an ambulatory approach, it has not
become widely accepted. Initial attempts at ambulatory cholecys-
tectomy reported high rates of readmission, which may well have
impaired its uptake, yet patients report high levels of satisfaction
when the procedure is performed well.6,7,18,81 As enhanced-
recovery surgery becomes mainstream for major procedures, it
has become clear that the most effective programmes are those
which take a multimodal approach to treatment.35,82 Thus, the aim
of this systematic review was to identify interventions that had the
potential to reduce postoperative pain, fatigue and PONV follow-
ing LC on the assumption that these symptoms are the main
barriers to an ambulatory approach to LC. It is possible that other
important factors may have been missed by this approach.
However, this would seem unlikely in view of the available evi-
dence for the causes of failed ambulatory cholecystectomy.5–7 A
total of 68 randomized trials met our study inclusion criteria and
five interventions were identified as having evidence strong
enough to support a Level IA recommendation.
Despite the large numbers of LC performed on a daily basis
around the world, only 22 of the trials examined in this review
enrolled over 100 patients. These were powered sufficiently for
primary outcome measures, but placed secondary outcome mea-
sures at significant risk of type II errors; consequently, further
trials are needed.
Pain following LC has been classified into three major types by
Joris et al.50 These include shoulder-tip pain, visceral pain (deep,
dull pain that is hard to localize) and parietal pain (surface or
wound-type pain). Joris et al.50 demonstrated that visceral pain
features in the first 24 h postoperatively, but is short-lived,
whereas shoulder-tip pain is minor and features on postoperative
day 2. These findings, however, contrast with those of Sarli et al.,44
who reported that shoulder-tip pain started at 3–6 h postopera-
tively, peaked at 12 h and rapidly improved thereafter. What is
clear is that a single agent is unlikely to treat all three types of pain
and a multimodal approach will be required.
Although almost all of the trials that assessed postoperative
pain used VAS scores and/or postoperative analgesic require-
ments, the significant variations in technique, trial design, time at
which data were measured and type of postoperative analgesia
make it impossible to perform a meta-analysis and make inter-
trial comparisons difficult. Similar issues exist in terms of varia-
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tions in definitions of PONV, timing of measurement and use of
postoperative rescue anti-emetics.
The other significant issue is that many trials showed statisti-
cally significant reductions in VAS pain scores which may not
truly represent clinically significant reductions in pain. It is gen-
erally accepted that a clinically significant result for trials assess-
ing pain should report a 2-point decrease (on a 10-point scale)
or a 30% reduction in VAS scores.83 Similarly, when pain is con-
sidered to be ‘mild’ to begin with (i.e. as reflected by a pain score
of <4/10), it may be difficult to interpret any reduction as clini-
cally meaningful. Future trials may need to overcome this by
using more clinically relevant outcome measures, such as
time to discharge or time to return to normal activities, as
primary endpoints.
A further significant trend concerned the impact of the timing
of the intervention on postoperative pain. It would seem that
pre-emptive administration is important if the intervention is to
be effective. For example, seven trials attempted to determine the
effect of dexamethasone on PONV: in two trials, in which the
treatment was administered 90 min prior to induction, significant
reductions in postoperative pain scores were observed, but these
effects were not seen when dexamethasone was given at induction.
Similarly, preoperative analgesia, pre-incisional use of local anaes-
thetic, and administration of intraperitoneal local anaesthetic as
soon as pneumoperitoneum is established and prior to perform-
ing cholecystectomy all appear to be important if the intervention
is to be effective.
From the data assessed, it is clear that multiple interventions
have been shown to be effective in improving outcomes following
LC. Although multimodal interventional trials have been identi-
fied and many of these used a standardized approach, none
included all of the interventions identified as useful. Many studies
investigating PONV included the use of agents known to be eme-
togenic such as nitrous oxide, neostigmine and even volatile ana-
esthesia.84 If the goal of the intervention is early discharge, it
would make sense to use agents that are not associated with
PONV.
It is therefore unclear which combination of interventions is
necessary to achieve optimal rates of ambulatory LC. Given the
high number of potential interventions, it would seem unlikely
that an RCT could be designed to establish the optimal combina-
tion of interventions. Instead, it may be more practical and timely
to design a clinical pathway or protocol which combines these
evidence-based interventions and which measures predefined
dichotomous outcomes, such as successful discharge within 6 h or
12 h, and time to return to work. Interventions could then be
added or subtracted, their effects measured and analysed, and
appropriate recommendations made.
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Appendix
Protocol for the systematic review
of factors facilitating ambulatory
laparoscopic cholecystectomy
Objective
To identify preoperative, intraoperative and postoperative inter-
ventions to optimize the success of ambulatory cholecystectomy.
Hypotheses
1 That ambulatory laparoscopic cholecystectomy is feasible, safe
and effective
2 That pain, postoperative nausea and vomiting and low levels of
patient satisfaction are barriers to ambulatory laparoscopic
cholecystectomy
Literature search
Databases searched: OVID PubMed and CENTRAL (Cochrane
Central Register of Controlled Trials) using the following strategy:
1 Search term: cholecystectomy, laparoscopic/OR laparoscopic
cholecystectomy.mp
2 Search term: ambulatory surgical procedures/
3 Search term: anaesthesia/
4 Search term: preoperative care/
5 Search term: postoperative care/
6 Search term: intraoperative care/
7 Search term: patient education as Topic/ OR patient educa-
tion.mp
8 Search term: drainage/ OR drainage.mp
9 Limited to English-language studies
10 Limited to human studies
11 Limited to randomized controlled trials only
Additionally, any article that was unavailable in full-text online
was explored using the ‘find similar’ function. Ovid MEDLINE
was used to retrieve full-text articles if they were not available
from PubMed.
Search 1 – 1 AND 2 WITH 9, 10, 11. (In CENTRAL, the use
of the English language was manually established by
reading abstracts)
Search 2 – 1 AND 3 WITH 9, 10, 11
Search 3 – 1 AND 4 WITH 9, 10, 11
Search 4 – 1 AND 5 WITH 9, 10, 11
Search 5 – 1 AND 6 WITH 9, 10, 11
Search 6 – 1 AND 7 WITH 9, 10, 11
Search 7 – 1 AND 8 WITH 9, 10, 11
Inclusion criteria
A study will be included in the systematic review if it meets the
following criteria:
1 The participant population is identified as patients undergoing
laparoscopic cholecystectomy
2 The studied intervention is compared with a control
3 The primary outcome measure signifies the studied interven-
tion’s efficacy on enhanced recovery and, hence, faster dis-
charge from hospital after the procedure (e.g. postoperative
pain, postoperative nausea and vomiting, patient satisfaction,
number of hours until discharge)
4 It is published in English
Exclusion criteria
A study will be excluded from the review if it meets one or more
of the following criteria:
1 It aims to prove the safety, feasibility and/or efficacy of ambu-
latory laparoscopic cholecystectomy compared with an inpa-
tient procedure
2 It has amixed-participant population fromwhich themeasured
outcomes in a laparoscopic cholecystectomy patient population
cannot be delineated
3 It investigates patient characteristics as predictors of success in
ambulatory laparoscopic cholecystectomy
4 It uses outcome measures other than postoperative pain, post-
operative nausea and vomiting, patient satisfaction and time
until discharge
5 It is not published in English
6 It is not a randomized controlled trial
7 It achieves a Jadad score of <3
Document selection
1 Record the number of articles identified by each search strategy
2 Reviewer to assess title and abstracts identified from all searches
and retain full text of articles considered to meet the inclusion/
exclusion eligibility criteria
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3 Record the number of articles excluded as not relevant based on
the exclusion criteria
4 Reviewer to assess more closely the full manuscripts of retained
articles and apply all of the inclusion criteria
5 Record the number of articles excluded by this process
6 Record the number of full-text articles retained and evaluated
for full analysis
Data extraction
The following data will be extracted:
1 Author(s)
2 Year of publication
3 Number of participant population
4 Participant characteristics
5 Randomized controlled trial characteristics
6 Method of randomization
7 Intervention studied
8 Comparison(s) studied
9 Outcome(s) measured
10 Results
11 Conclusions
Assessment of study quality
Quality assessment of the studies will be performed using the
Jadad Scoring System score.8 A score of <3 will result in the exclu-
sion of the study from analysis.
686 HPB
HPB 2011, 13, 677–686 © 2011 International Hepato-Pancreato-Biliary Association
